Theranostic Approach in Breast Cancer: A Treasured Tailor for Future Oncology, PubMed.gov, Clin Nucl Med, 2021 Aug 1
Review on current status of preclinical and clinical research using theranostic approach in breast cancer patients with potential to translate into conventional treatment strategies alone or in combination with other common treatments.
PMID: 34152118, DOI: 10.1097/RLU.0000000000003678
Theranostic Advances in Breast Cancer in Nuclear Medicine, International Journal of Molecular Sciences, mdpi, Review.
The implication of ‘theranostic’ refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
Citation: Vahidfar, N.; Aghanejad, A.; Ahmadzadehfar, H.; Farzanehfar, S.; Eppard, E. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Int. J. Mol. Sci. 2021, 22, 4597. https://doi.org/10.3390/ijms22094597